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Abstract We investigated the contribution of the intra-
cellular calcium (Cai
2?) transient to acetylcholine (ACh)-
mediated reduction of pacemaker frequency and cAMP
content in rabbit sinoatrial nodal (SAN) cells. Action
potentials (whole cell perforated patch clamp) and Cai
2?
transients (Indo-1 ﬂuorescence) were recorded from single
isolated rabbit SAN cells, whereas intracellular cAMP
content was measured in SAN cell suspensions using a
cAMP assay (LANCE
). Our data show that the Cai
2?
transient, like the hyperpolarization-activated ‘‘funny cur-
rent’’ (If) and the ACh-sensitive potassium current (IK,ACh),
is an important determinant of ACh-mediated pacemaker
slowing. When If and IK,ACh were both inhibited, by cesium
(2 mM) and tertiapin (100 nM), respectively, 1 lM ACh
was still able to reduce pacemaker frequency by 72%. In
these If and IK,ACh-inhibited SAN cells, good correlations
were found between the ACh-mediated change in interbeat
interval and the ACh-mediated change in Cai
2? transient
decay (r
2 = 0.98) and slow diastolic Cai
2? rise (r
2 = 0.73).
Inhibition of the Cai
2? transient by ryanodine (3 lM) or
BAPTA-AM (5 lM) facilitated ACh-mediated pacemaker
slowing. Furthermore, ACh depressed the Cai
2? transient
and reduced the sarcoplasmic reticulum (SR) Ca
2? content,
all in a concentration-dependent fashion. At 1 lM ACh,
the spontaneous activity and Cai
2? transient were abolished,
but completely recovered when cAMP production was
stimulated by forskolin (10 lM) and IK,ACh was inhibited
by tertiapin (100 nM). Also, inhibition of the Cai
2? tran-
sient by ryanodine (3 lM) or BAPTA-AM (25 lM)
exaggerated the ACh-mediated inhibition of cAMP con-
tent, indicating that Cai
2? affects cAMP production in SAN
cells. In conclusion, muscarinic receptor stimulation
inhibits the Cai
2? transient via a cAMP-dependent signaling
pathway. Inhibition of the Cai
2? transient contributes to
pacemaker slowing and inhibits Cai
2?-stimulated cAMP
production. Thus, we provide functional evidence for the
contribution of the Cai
2? transient to ACh-induced inhibi-
tion of pacemaker activity and cAMP content in rabbit
SAN cells.
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Introduction
The mechanisms underlying pacemaker activity of sino-
atrial node (SAN) cells are still a matter of debate [14, 17,
19, 20, 24]. Classically, b-adrenergic and muscarinic
modulation of SAN pacemaker activity is explained by
cAMP and PKA-dependent acceleration or deceleration of
the ‘‘membrane clock’’, which consists of time- and volt-
age-dependent ion channels located in the plasma mem-
brane of SAN cells [26]. Noradrenaline (NA) increases the
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zation [4], including the hyperpolarization-activated cation
current (If)[ 7], L-type Ca
2? current (ICa,L)[ 12] and sus-
tained inward current (Ist)[ 11, 32]. In addition, outward
currents are reduced by hastening deactivation of the total
delayed rectiﬁer current (IK)[ 22]. On the other hand,
acetylcholine (ACh) slows the diastolic depolarization [4,
52] by decreasing the inward currents, If [8], ICa,L [34] and
Ist [10], and activating the outward current IK,ACh [37].
Only during the last decade, spontaneous Ca
2? releases
from the sarcoplasmic reticulum (SR) have been widely
recognized as an additional pacemaker mechanism: the
‘‘calcium clock’’ [26]. It was demonstrated that inhibition
of the ‘‘calcium clock’’ largely prevented b-adrenergic
speeding of the pacemaker rate [25, 36]. Although pace-
maker cells lack T-tubules, have sparsely developed SR,
and contain little contractile proteins [29], they are
endowed with signiﬁcant intracellular Ca
2? (Cai
2?) tran-
sients [23]. b-adrenergic stimulation augments the ampli-
tude of the Cai
2? transients and the local Ca
2? releases
(LCRs) from the SR late during the diastolic depolarization
[26]. Besides the amplitude, also the frequency at which
the LCRs occur increases [26]. The accelerated ‘‘calcium
clock’’ dynamically interacts with the ‘‘membrane clock’’
through the LCR-driven activation of an inwardly directed
Na
?/Ca
2? exchange current (INCX)[ 28], which substan-
tially contributes to the diastolic depolarization rate and to
the ignition of the action potential (AP) [3]. The augmented
Cai
2? transients and the accelerated ‘‘calcium clock’’ are
the consequence of b-adrenergic-mediated cAMP produc-
tion and increased PKA-dependent phosphorylation of
Ca
2? handling proteins [46]. The Cai
2? transients and
‘‘calcium clock’’ are interdependent [26]. At every beat, the
‘‘calcium clock’’ is reset by ICa,L that subsequently triggers
aC a i
2? transient. Only after the Cai
2? transient has sufﬁ-
ciently declined and enough Ca
2? is restored in the SR,
LCRs can again occur. This makes the Cai
2? transient an
integral part of the ‘‘calcium clock’’ [25–27].
It has been hypothesized that Cai
2? also indirectly cou-
ples to the ‘‘membrane clock’’ via a route involving cAMP,
based on the observation that Cai
2? transient inhibition
abolished If modulation by b-adrenergic agonists, while a
membrane-permeable cAMP analog restored it [5]. Indeed,
Mattick et al. [30] recently identiﬁed Ca
2?-stimulated
adenylyl cyclase in guinea pig SAN cells that could explain
this interesting observation.
In summary, the afore-mentioned data from literature
show that b-adrenergic stimulation of SAN cells acceler-
ates both the ‘‘membrane clock’’ and the ‘‘calcium clock’’
and augments the Cai
2? transient via cAMP–PKA-depen-
dent signaling pathways. Moreover, evidence has been
provided that Cai
2? stimulates cAMP production. We
hypothesized that muscarinic receptor stimulation would
lead to the opposite effects. In the present study, we carried
out experiments on isolated rabbit SAN cells to determine
(1) whether Cai
2? transients, such as If and IK,ACh, are
important determinants of ACh-mediated pacemaker
slowing, and (2) whether inhibition of Cai
2? transients by
muscarinic agonists lowers cAMP production. Our results
demonstrate the importance of Cai
2? transients in ACh-
induced inhibition of pacemaker frequency and cAMP
content in rabbit SAN cells.
Methods
Ethical approval and cell preparation
All experiments were carried out in accordance with
guidelines of the local institutional animal care and use
committee. In addition, the investigation conforms with the
Guide for the Care and Use of Laboratory Animals pub-
lished by the US National Institutes of Health (NIH Pub-
lication No. 85-23, revised 1996). Single SAN cells were
isolated from 42 rabbit hearts by an enzymatic dissociation
procedure as previously described [42]. The hearts were
obtained from New Zealand White rabbits (body weight:
3.0–3.5 kg) were ﬁrst sedated with a 1 ml kg
-1 intramus-
cular injection of Hypnorm
 (10 mg ml
-1 ﬂuanisone and
0.315 mg ml
-1 fentanyl citrate; Janssen Pharmaceutics,
Tilburg, The Netherlands) and 15 min later anaesthetized
by an injection of 3.0–3.5 ml Nembutal
 (60 mg ml
-1
pentobarbital sodium; Sanoﬁ, Maassluis, The Netherlands)
in the marginal ear vein together with 0.3 ml
heparin (5,000 IU ml
-1 thromboliquine; Organon, Oss,
The Netherlands). For all measurements, except cAMP
determination, spindle and elongated spindle-like cells
displaying regular contractions in normal Tyrode’s solution
were selected.
Electrophysiology
APs were recorded at 36 ± 0.2C with the amphotericin B
perforated patch-clamp technique using an Axopatch 200B
patch-clamp ampliﬁer (Molecular Devices Corporation,
Sunnyvale, CA, USA). Patch pipettes (2–5 MX) were
pulled from borosilicate glass, and data acquisition and
analysis were accomplished using pCLAMP 8 software
(Molecular Devices). Signals were low-pass ﬁltered with a
1 kHz cutoff frequency, and digitized at 2 kHz. Potentials
were corrected for the calculated liquid junction potential
(13 mV). Cell membrane capacitance was estimated by
dividing the decay time constant of the capacitive transient
in response to 5-mV hyperpolarizing voltage clamp steps
from 0 mV by the series resistance, and amounted to
34 ± 3p F( m e a n± SEM; n = 12).
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2? measurements
[Ca
2?]i was measured in Indo-1 loaded cells. In brief, cells
were loaded with 5 lM Indo-1-AM for 10 min at room
temperature, and subsequently superfused with normal
Tyrode’s solution for 15 min at 36 ± 0.2C to remove
excess indicator and allow full de-esteriﬁcation. A rectan-
gular adjustable slit was used to select a single cell and to
reduce background ﬂuorescence. Dye-loaded cells were
excited with 340 nm light (75 W Xenon arc lamp) and
ﬂuorescent light intensities were measured at 405 (I405) and
505 (I505) nm, using photomultiplier tubes. Signals were
digitized at 1 kHz, ﬁltered at 100 Hz, and corrected for
background ﬂuorescence before the I405/I505 ratio values
were calculated.
[Ca
2?]i was computed from [Ca
2?]i = b 9 Kd 9 (R -
Rmin)/(Rmax - R), where b represented the ratio of maxi-
mal I505 and minimal I505 (2.2), Kd was 250 nM (data sheet
from Molecular Probes, Eugene, OR, USA), and Rmin and
Rmax were the minimal and maximal ratio, respectively. To
determine Rmin and Rmax, the cells were made Ca
2? per-
meable with a high potassium solution containing 1.7 lM
A23187, 5 lM gramicidin and 10 lM nigericin, while
Ca
2? re-uptake was inhibited by 5 lM thapsigargin. In the
absence of Ca
2?, we obtained an Rmin value of 0.31 ± 0.04
(n = 24), whereas in the presence of 10 mM extracellular
Ca
2? the Rmax value was 2.21 ± 0.24 (n = 24).
The SR Ca
2? content of cells was studied by a brief
exposure, via a nearby pipette, to 20 mM caffeine and
5 mM nickel to release Ca
2? from the SR and to prevent
Ca
2? efﬂux by Na
?/Ca
2? exchange, respectively. The
fractional SR Ca
2? release was determined by normalizing
the preceding Cai
2? transient amplitude (average of 6) to
the caffeine-evoked Cai
2? transient amplitude.
cAMP measurements
The LANCE cAMP kit (PerkinElmer, Zaventem, Belgium)
was used to determine cAMP concentrations (according to
the manufacturer’s instruction) using a Victor plate reader
(Wallac, PerkinElmer, Zaventem, Belgium). Cell suspen-
sion was added to a 384-well OptiPlate (PerkinElmer,
Waltham, MA, USA; 5 ll per well) and incubated for 1 h
at room temperature with metacholine (MCh) at concen-
trations ranging from 10
-10 to 10
-5 M. All experiments
were performed in the presence of 0.05% bovine serum
albumin (BSA) and 500 lM of the phosphodiesterase
inhibitor isobutyl-methyl-xanthine (IBMX) to allow accu-
mulation of cAMP.
For every experiment, the yields of two SAN cell iso-
lations were pooled and divided over different wells. All
MCh–cAMP response curve measurements were per-
formed in triplo and averaged. For each intervention
(500 nM NA, 3 lM ryanodine, 25 lM BAPTA-AM), a
control MCh–cAMP response curve was measured in the
presence of the vehicle used. The obtained cAMP values
were normalized to the control cAMP value measured in
the absence of MCh. To determine the effect of Cai
2? on
cAMP content, SAN cells were pre-incubated with BAP-
TA-AM or ryanodine for 10 min.
Solutions and drugs
Solutions
Tyrode’s solution contained (mM): 140 NaCl, 5.4 KCl, 1.8
CaCl2, 1.0 MgCl2, 5.5 glucose, 5.0 HEPES; pH 7.4 (2.6
NaOH). The pipette solution contained (mM): 120 K-glu-
conate, 20 KCl, 5 NaCl, 0.22 amphothericin B, 10 NMDG-
Cl (N-methyl-D-glucammonium chloride), 10 HEPES; pH
7.2 (5.5 KOH). The high potassium solution contained
(mM): 130 KCl, 10 NaCl, 1 MgCl2, 10 HEPES; pH 7.2 (5.5
KOH).
Drugs
All drugs were obtained from Sigma (Zwijndrecht, The
Netherlands), except ryanodine (Calbiochem-Novabio-
chem, Darmstadt, Germany; 10 mM), noradrenaline
(Centrafarm, Etten-Leur, The Netherlands; 6 mM), Indo-1,
BAPTA-AM, and thapsigargin (Molecular Probes). Except
for noradrenaline, all drugs were prepared as a stock
solution in DMSO (amphothericin B (65 mM), Indo-1
(5 mM), A23187 (1.7 mM), thapsigargin (10 mM), BAP-
TA-AM (25 mM), forskolin, (10 mM)), in ethanol (grami-
cidin (50 mM), nigericin (10 mM)), or in H2O( A C h
(1 mM), ryanodine (3 mM), MCh (10 mM)). The values in
parentheses indicate the concentration of the stock. The
ryanodine and BAPTA-AM concentrations were such that
Cai
2? transients were largely, but not fully, inhibited,
whereas the cesium and tertiapin concentrations were
selected to maximally inhibit If and IK,ACh, respectively,
without exerting major effects on other membrane currents.
We chose 3 lM ryanodine since it has often been used,
e.g., by Bogdanov et al. [3], Bucchi et al. [5] and Vinog-
radova et al. [46], and higher concentrations are known to
block ICa,L [38]. A sub-maximal NA concentration
(500 nM) was selected to study the anti-adrenergic effects
of ACh on Cai
2? transients and pacemaker frequency.
Ryanodine, BAPTA-AM, MCh, ACh and NA were pre-
pared freshly on the day of the experiment. The effect of
ACh, NA, cesium and tertiapin on pacemaker frequency
was determined after 2 min exposure time, whereas the
effect of ryanodine and BAPTA-AM was determined after
10 min.
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Results are expressed as mean ± SEM, with the number of
cells or cell suspensions denoted by n. Statistical analysis
was performed using SPSS 10 software (SPSS Inc., Chi-
cago, IL, USA). Two-way ANOVA with repeated mea-
surements was used to compare concentration effect
curves, whereas the EC50 values (derived from a Hill
equation ﬁt) and the pacemaker frequencies of Fig. 2b were
compared with a Student’s t test. One-way ANOVA with
repeated measurements, followed by a Student–Newman–
Keuls test for pairwise comparsions, was used to compare
the pacemaker frequencies of Fig. 2f. P values of \0.05
were considered to be signiﬁcant.
Results
Determination of pacemaker frequency by Cai
2?
transients
Consistent with previous reports [20], spontaneous APs in
single SAN cells are accompanied by Cai
2? transients in a
1:1 fashion, both under control conditions (Fig. 1a, black
traces) and in the presence of NA (Fig. 1a, red traces) or
both NA and ACh (Fig. 1a, blue traces). Consequently, a
good correlation between the cycle length of the sponta-
neous Cai
2? transients and that of the associated APs was
observed (r
2 = 0.98) (Fig. 1b). Therefore, the average
cycle length of ten consecutive spontaneous Cai
2? tran-
sients was used to determine pacemaker frequency. While
every AP is accompanied by a Cai
2? transient, APs and
Cai
2? transients are not exactly synchronized. In the
absence of ACh and NA, maximal upstroke velocity of the
Cai
2? transient occurred 21.3 ± 0.6 ms (n = 8) later than
the maximum upstroke velocity of the action potential.
Inhibition of cAMP production and activation
of IK,ACh underlie pacemaker slowing
Classically, reduction of pacemaker frequency by ACh is
explained by slowing of the ‘‘membrane clock’’ through a
muscarinic receptor-regulated signaling pathway [4]. Our
main objective in this study is to elucidate the possible role
of Cai
2? transients in muscarinic agonist-induced pace-
maker slowing (Fig. 2a, gray area). We hypothesize that
muscarinic agonists slow pacemaking partly by reducing
Cai
2? transients through inhibiting cAMP–PKA-dependent
phosphorylation of Cai
2? handling proteins. This subse-
quently affects Ca
2?-dependent currents and reduces
pacemaker frequency by decreasing INCX,C a
2?-stimulated
cAMP production, and cAMP and PKA-dependent inward
currents (Fig. 2a, gray area). Before we study the role of
Cai
2? transients in muscarinic agonist-induced pacemaker
slowing, we will ﬁrst examine some classical pathways in
our rabbit SAN cell model. As illustrated in Fig. 2a,
muscarinic receptor stimulation directly activates IK,ACh
and indirectly decreases If, ICa,L and Ist via reduced cAMP
or PKA-dependent modulation. Because the effect of
muscarinic agonists largely depends on the absolute cAMP
levels, studies were performed in the absence (non-stimu-
lated) and presence of 500 nM NA (NA stimulated).
In NA-stimulated SAN cells, pacemaker frequency, as
derived from Cai
2? transients, was signiﬁcantly higher
compared to non-stimulated SAN cells (3.94 ± 0.11 Hz,
n = 22, vs. 3.31 ± 0.17 Hz, n = 13, respectively) (Fig. 2b).
In both groups, pacemaker frequency decreased with
increasing ACh concentrations (12.5, 50, 100 and
1,000 nM; Fig. 2c). However, the relative decrease in
pacemaker frequency was signiﬁcantly larger in non-
stimulated compared to NA-stimulated cells at ACh con-
centrations of 12.5, 50 and 100 nM (Fig. 2c, asterisks).
Accordingly, the averaged EC50 value of the individual
Fig. 1 Cai
2? transients and
action potentials in a rabbit
SAN cell. a A typical
simultaneous recording of
action potentials (upper panel)
and Cai
2? transients (lower
panel) in normal Tyrode’s
solution (black traces), in the
presence of 500 nM NA alone
(red traces) or combined with
50 nM ACh (blue traces).
b Cycle length of action
potentials versus cycle length of
the associated Cai
2? transients
(r
2 = 0.98)
76 Basic Res Cardiol (2010) 105:73–87
123Fig. 2 Muscarinic agonist-induced pacemaker slowing. a Muscarinic
receptor (M2) stimulation reduces pacemaker rate by down-regulation
of inward membrane currents (If, Ist, ICa,L) through inhibition of
cAMP production and up-regulation of the outward IK,ACh. The main
objective of the present study is to elucidate the possible role of Cai
2?
transients in muscarinic agonist-induced pacemaker slowing (gray
area). b Intrinsic pacemaker frequency of non-stimulated (white bars)
and 500 nM NA-stimulated (gray bars) SAN cells in the absence of
muscarinic agonists. c Frequency–ACh relationship for non-stimu-
lated and NA-stimulated SAN cells. Inset shows average EC50 values
of the frequency–ACh relationships of individual cells. d cAMP–
MCh relationship for non-stimulated and NA-stimulated SAN cells.
Inset shows average EC50 values of the cAMP–MCh relationships of
individual cells. e Typical Cai
2? transients of a SAN cell successively
exposed to normal Tyrode’s solution (black trace), 1 lM ACh (red
trace), 1 lM ACh ? 100 nM tertiapin (blue trace) and 1 lM
ACh ? 100 nM tertiapin ? 10 lM forskolin (green trace). f Mean
frequency of six non-stimulated SAN cells successively exposed to
the solutions of panel E. Quiescent SAN cells (ACh) regained
spontaneous activity on inhibition of IK,ACh (ACh ? tertiapin),
whereas pacemaker frequency was fully restored to control values
on additional stimulation of cAMP production (ACh ? tertia-
pin ? forskolin). Asterisks indicate signiﬁcant differences (P\0.05)
Basic Res Cardiol (2010) 105:73–87 77
123frequency–ACh relations of the 13 non-stimulated SAN
cells tested (30 ± 2 nM) was signiﬁcantly smaller than
that for the 22 NA-stimulated cells tested (45 ± 4 nM)
(Fig. 2c, inset).
Determination of cAMP accumulation in SAN cell
suspensions showed that stimulation of the muscarinic
receptor by metacholine (MCh), an ACh analog that cannot
be hydrolyzed by acetylcholinesterase possibly present in
the cell suspension, inhibits cAMP accumulation concen-
tration dependently in both non-stimulated (n = 8) and
NA-stimulated (n = 8) cells (Fig. 2d). In NA-stimulated
SAN cells, the accumulated cAMP was signiﬁcantly higher
in basal conditions (no MCh) compared to non-stimulated
cells and showed a smaller percent decrease with increas-
ing MCh concentrations (ANOVA, P\0.05). Accord-
ingly, the averaged EC50 value of the individual cAMP
Fig. 3 Contribution of If and
IK,ACh to muscarinic agonist-
induced pacemaker slowing.
If and IK,ACh were inhibited by
2 mM cesium and 100 nM
tertiapin, respectively. a Typical
Cai
2? transients of non-
stimulated SAN cells in the
absence (Tyrode) and presence
of cesium (left panel)o r
tertiapin (right panel).
b, c Frequency–ACh
relationship under control
conditions (ctrl), in the presence
of cesium, and in the presence
of tertiapin in non-stimulated
(b) and NA-stimulated (c) cells.
Asterisks indicate signiﬁcant
difference from control at the
associated ACh concentration
Fig. 4 Contribution of Cai
2?
transients to muscarinic agonist-
induced pacemaker slowing.
Cai
2? transients were inhibited
by 3 lM ryanodine or 5 lM
BAPTA-AM. a Typical Cai
2?
transients of non-stimulated
SAN cells before (Tyrode) and
after treatment with ryanodine
(left panel) or BAPTA (right
panel). b, c Frequency–ACh
relationship under control
conditions (ctrl), in the presence
of ryanodine, and in the
presence of BAPTA in non-
stimulated (b) and NA-
stimulated (c) cells. Asterisks
indicate signiﬁcant difference
from control at the associated
ACh concentration
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Fig. 2d, inset) proved signiﬁcantly higher in NA-stimulated
compared to non-stimulated cells. Interestingly, the EC50
values of the pacemaker frequency–ACh and the cAMP
accumulation–MCh relations (Fig. 2c, d, insets) are both
increased by &50% in NA-stimulated cells compared to
non-stimulated cells, suggesting a strong correlation
between muscarinic agonist-induced frequency and cAMP
changes.
Next, we examined whether activation of IK,ACh and
inhibition of cAMP production can explain pacemaker
slowing by muscarinic agonists. Therefore, we tested the
effects of the IK,ACh blocker tertiapin and the adenylyl
cyclase activator forskolin on 1 lM ACh effects in non-
stimulated SAN cells (n = 6). Typical Cai
2? transients
recorded under these conditions are depicted in Fig. 2e.
Spontaneous activity recovered partially by IK,ACh block-
ade (tertiapin 100 nM) and fully when in addition adenylyl
cyclase was activated (forskolin 10 lM) (Fig. 2f; blue and
green bars, respectively). From these data, we conclude
that inhibition of cAMP production and activation of IK,ACh
could explain the effect of muscarinic receptor stimulation
on pacemaker frequency.
Contribution of If and IK,ACh to ACh-mediated
pacemaker slowing
Next, we examined the contribution of the cAMP-depen-
dent If and cAMP-independent IK,ACh pathways to ACh-
mediated pacemaker slowing. Although other membrane
ionic currents, speciﬁcally ICa,L and Ist (Fig. 2a), also con-
tribute to ACh-mediated pacemaker slowing, we focused on
If and IK,ACh, because speciﬁc blockers of these currents are
available and full blockade of these currents does not result
in pacemaker arrest. In non-stimulated cells and in the
absence of ACh, If inhibition (2 mM cesium) signiﬁcantly
reduced pacemaker frequency (Fig. 3a, left panel), whereas
IK,ACh inhibition (100 nM tertiapin) did not affect pace-
maker frequency(Fig. 3a, right panel). Similar observations
were made in NA-stimulated cells (not shown). The percent
reduction in pacemaker frequency on inhibition of If was
similar in non-stimulated and NA-stimulated cells (&30
and &33%, respectively; Fig. 3b, c, data at 0 nM ACh).
In non-stimulated SAN cells, the If blocker cesium
(2 mM; n = 10) slowed pacemaking only at low ACh
concentrations (\50 nM), whereas the IK,ACh blocker ter-
tiapin (100 nM; n = 9) opposed pacemaker slowing at all
ACh concentrations tested (Fig. 3b) (ANOVA, P\0.05).
In NA-stimulated cells, pacemaker slowing by the If
blocker cesium (n = 8) was visible up to 100 nM ACh
(ANOVA, P\0.05), whereas the IK,ACh blocker tertiapin
(n = 4) no longer signiﬁcantly opposed pacemaker slow-
ing (Fig. 3c). These results demonstrate that If and IK,ACh
contribute to ACh-mediated pacemaker slowing. If gains
importance and IK,ACh loses importance in ACh-mediated
pacemaker slowing under NA-stimulated conditions.
However, ACh-mediated pacemaker slowing was still
clearly present during If or IK,ACh blockade, indicating the
contribution of other mechanisms (see below).
Contribution of Cai
2? transients to ACh-mediated
pacemaker slowing
SAN pacemaker activity has been shown to be modulated
also by SR Ca
2? loading and release [26]. Therefore, we
next examined the role of Cai
2? transients in ACh-induced
pacemaker slowing.
First, we tested the effect of Cai
2? transient inhibition on
spontaneous activity of SAN cells in the absence of ACh.
Figure 4a shows typical Cai
2? transients of non-stimulated
SAN cells exposed to the SR Ca
2? release blocker ryano-
dine (3 lM) or the Ca
2? chelator BAPTA-AM (5 lM).
Both drugs decreased the maximum systolic Cai
2? concen-
tration, with the larger decrease in the presence of BAPTA-
AM. In addition, both drugs caused an elevation of the
minimum diastolic Cai
2? level, which was highest in the
presence of 3 lM ryanodine. On average, 10 min exposure
to ryanodine or BAPTA-AM signiﬁcantly (P\0.05)
reduced pacemaker frequency in non-stimulated SAN cells
by 22% (n = 8) and 37% (n = 7), respectively, and in NA-
stimulated SAN cells by 16% (n = 10) and 30% (n = 4)
(Fig. 4b, c, at 0 nM ACh). This indicates that Cai
2? tran-
sients contribute to pacemaker activity of both non-stimu-
lated and NA-stimulated SAN cells.
Second, we tested the effects of ryanodine and BAPTA-
AM on ACh-induced pacemaker slowing. In non-stimu-
lated SAN cells, BAPTA-AM, but not ryanodine, caused a
clear slowing at the low ACh concentration of 12.5 nM
(Fig. 4b), whereas in NA-stimulated cells both agents
exaggerated pacemaker slowing at ACh concentrations of
12.5, 50 and 100 nM (Fig. 4c) (ANOVA, P\0.05). Taken
together, these data demonstrate that Cai
2? transients can
contribute to ACh-induced pacemaker slowing.
Effect of ACh on Cai
2? transients
Cai
2? transients of SAN cells
According to the important role of Cai
2? transients in ACh-
induced pacemaker slowing (Fig. 4), we analyzed the
effects of ACh on Cai
2? transient characteristics in detail
(Fig. 5). We discerned ﬁve distinct phases (numbered I–V)
in Cai
2? transients of SAN cells. Figure 5a shows a typical
example of the various Cai
2? transient phases in a non-
stimulated cell in the absence of ACh. The Cai
2? transient
was quantiﬁed by (1) the maximum rate of the fast systolic
Basic Res Cardiol (2010) 105:73–87 79
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2?]i rise during phase I following the fast AP upstroke,
(2) the maximum systolic [Ca
2?]i level during phase II, (3)
the time constant of the monoexponential [Ca
2?]i decay
during phase III, (4) the minimum diastolic [Ca
2?]i level
during phase IV reached after completing about two-thirds
of diastolic depolarization, and (5) the mean rate of the
slow diastolic [Ca
2?]i rise during phase V following the
ﬁnal third of diastolic depolarization until the next AP
upstroke. As well known [26], NA stimulation increased
d[Ca
2?]i/dt during the upstroke (phase I (Fig. 5b)), the
systolic Ca
2? concentration (phase II (Fig. 5c)) and dia-
stolic d[Ca
2?]i/dt (phases III (Fig. 5d) and V (Fig. 5f)).
Effect of ACh on Cai
2? transients
We then analyzed the effects of ACh on the Cai
2? transient
characteristics in both non-stimulated (n = 13) and NA-
stimulated (n = 22) SAN cells in detail. Figure 5b, c, d, e,
f shows that all ﬁve phases were affected concentration
dependently in both non-stimulated and NA-stimulated
cells. The fast systolic [Ca
2?]i rise slowed (Fig. 5b), the
maximum systolic [Ca
2?]i fell (Fig. 5c), the diastolic
[Ca
2?]i decay slowed (Fig. 5d), the minimum diastolic
[Ca
2?]i fell (Fig. 5e) and the diastolic [Ca
2?]i rise slowed
(Fig. 5f). Of note, phase V of the Cai
2? transient proved
Fig. 5 ACh inhibits Cai
2?
transients. a Superimposed
action potentials (red trace) and
associated Cai
2? transients (blue
trace) recorded in a non-
stimulated rabbit SAN cell in
the absence of ACh. Numbers
I–V indicate different phases of
the Cai
2? transient. b–f Effects
of ACh on rate of fast systolic
[Ca
2?]i rise (b), maximum
systolic [Ca
2?]i (c), time
constant of diastolic [Ca
2?]i
decay (d), minimum diastolic
[Ca
2?]i (e) and rate of diastolic
[Ca
2?]i rise (f) in non-
stimulated (circles) and NA-
stimulated (triangles) rabbit
SAN cells. Asterisks indicate
signiﬁcant difference
(P\0.05) between non-
stimulated and NA-stimulated
SAN cells at the associated ACh
concentration
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123most sensitive to ACh and was inhibited by 94 and 87% at
100 nM ACh in non-stimulated and NA-stimulated SAN
cells, respectively. Moreover, the diastolic [Ca
2?]i rise of
phase V proved also most sensitive to NA stimulation and
increased by 70% at 0 nM ACh (Fig. 5f).
From these data, we conclude that ACh inhibited the
Cai
2? transients in both non-stimulated and NA-stimulated
SAN cells.
Effect of ACh on SR Ca
2? content
To test whether the changed Cai
2? transients were associ-
ated with reduced SR Ca
2? loading and/or reduced SR Ca
2?
release, we studied SR Ca
2? content and fractional SR Ca
2?
release. Therefore, we measured SR Ca
2? release in
response to 20 mM caffeine, in the presence of 5 mM
nickel to block the Na
?/Ca
2? exchanger. Figure 6a shows
an example of three consecutive caffeine-evoked Cai
2?
transients measured in one cell in the absence and presence
of ACh (12.5 and 50 nM). In all conditions, emptying of the
SR abolished spontaneous Cai
2? transients until the SR
Ca
2? content was restored. Figure 6b summarizes the caf-
feine-induced Ca
2? release in non-stimulated and NA-
stimulated cells in the absence and presence of ACh. In both
non-stimulated and NA-stimulated cells, the SR Ca
2?
release fell concentration dependently with increasing ACh
concentrations. In NA-stimulated SAN cells, the SR Ca
2?
release provedsigniﬁcantly higher (ANOVA, P\0.05). As
shown in Fig. 6c, the fractional SR Ca
2? release was not
signiﬁcantly affected by ACh and did also not differ
between both non-stimulated and NA-stimulated SAN cells.
From these data we conclude that ACh lowers SR Ca
2?
content, which could explain the inhibitory effect of ACh
on Cai
2? transients (Fig. 5).
Phases III and V of the Cai
21 transient correlate with
pacemaker slowing
ACh-mediated slowing of the diastolic Cai
2? transient
phases III and V could contribute to the ACh-mediated
slowing of the diastolic depolarization rate and pacemaker
frequency. Phase III reﬂects SERCA activity, whereas
phase V likely reﬂects the LCRs observed by confocal
microscopy [25–27]. Both SERCA activity (phospholam-
ban phosphorylation) and LCRs have been shown to
exhibit a strong correlation with pacemaker frequency of
rabbit SAN cells [47]. Here, we examined the correlation
between the ACh-mediated change in the diastolic Cai
2?
phases III and V and the ACh-mediated change in interbeat
interval (IBI) in non-stimulated SAN cells (n = 14), when
the other important contributors to ACh-mediated pace-
maker slowing If and IK,ACh were blocked by 2 mM cesium
and 100 nM tertiapin, respectively. Figure 7a shows typi-
cal examples of Cai
2? transients recorded from a
Fig. 6 ACh lowers SR Ca
2?
content. a Typical effects of
caffeine in a non-stimulated
SAN cell. Instantaneous release
of Ca
2? from the SR was
evoked by application of a brief
exposure of the cell to 20 mM
caffeine plus 5 mM nickel to
prevent Cai
2? efﬂux through the
Na
?/Ca
2? exchanger (arrows).
b ACh dependence of SR Ca
2?
release on exposure to caffeine
in non-stimulated (circles) and
NA-stimulated (triangles) cells.
c ACh dependence of the
fractional SR Ca
2? release in
both non-stimulated (white
bars) and NA-stimulated (gray
bars) cells. Asterisks indicate
signiﬁcant difference between
non-stimulated and NA-
stimulated SAN cells at the
associated ACh concentration
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123non-stimulated SAN cell with inhibited If and IK,ACh that
was successively exposed to increasing ACh concentra-
tions (0, 12.5, 50, 100 and 1,000 nM). Under these con-
ditions, ACh inhibited Cai
2? transients (Fig. 7a) and slowed
pacemaker frequency (Fig. 7b) in a concentration-depen-
dent manner. Both the ACh-mediated changes in the dia-
stolic Cai
2? transient decay time (Fig. 7c, phase III) and the
diastolic Cai
2? rise (Fig. 7d, phase V) revealed close cor-
relations with the ACh-mediated changes in IBI. These
data support our hypothesis that ACh-mediated inhibition
of the diastolic Cai
2? transient phases III and V contributes
to ACh-mediated pacemaker slowing.
Effect of ryanodine and BAPTA-AM on intracellular
cAMP content
We found that ACh reduced pacemaker frequency, reduced
intracellular cAMP content and inhibited the Cai
2? tran-
sients. Recently, Ca
2?-stimulated adenylyl cyclases have
been identiﬁed in guinea pig SAN, suggesting that Cai
2?
could inﬂuence cAMP production [30]. In a ﬁnal series of
experiments, we therefore examined whether inhibition of
the Cai
2? transients by ryanodine or BAPTA-AM affected
the intracellular cAMP content. Figure 8 shows the effects
of muscarinic receptor stimulation by MCh on cAMP
content in both non-stimulated and NA-stimulated cells in
the presence of ryanodine or BAPTA-AM. Inhibition of
Cai
2? transients by 3 lM ryanodine signiﬁcantly (ANOVA,
P\0.05) reduced intracellular cAMP content in both non-
stimulated and NA-stimulated cells (Fig. 8a, b), with larger
effects in the NA-stimulated cells. Comparable signiﬁcant
(ANOVA, P\0.05) effects were found in the presence of
BAPTA-AM (Fig. 8c, d). Taken together, these data
demonstrate that inhibition of Cai
2? transients, e.g., by
ryanodine, BAPTA-AM or muscarinic receptor stimula-
tion, depresses cAMP production in rabbit SAN cells. This
is consistent with the presence of Ca
2?-stimulated adenylyl
cyclases, as identiﬁed in guinea pig SAN cells [30].
Discussion
In this study, we demonstrate for the ﬁrst time that mus-
carinic agonists inhibit Cai
2? transients in SAN cells, and
that the pacemaker slowing effects of muscarinic agonists
are augmented by Cai
2? transient inhibition. Moreover, we
provide evidence that, like muscarinic agonists, Cai
2?
transient inhibition reduces cAMP levels in SAN cells.
Both inhibition of Cai
2? transients and reduction of cAMP
levels will inhibit Cai
2? and cAMP-dependent ionic
Fig. 7 Diastolic Cai
2? transient
parameters correlate with
pacemaker frequency. a Typical
Cai
2? transients of a non-
stimulated SAN cell with
inhibited If (2 mM cesium) and
IK,ACh (100 nM tertiapin) that
was successively exposed to
normal Tyrode’s solution (black
trace), 12.5 nM ACh (red
trace), 50 nM ACh (blue trace),
100 nM ACh (green trace) and
1,000 nM ACh (purple trace). b
Average frequency–ACh
relationship of non-stimulated
SAN cells (n = 14) with
inhibited If and IK,ACh. c
Correlation between fold
change in interbeat interval
(IBI) and fold change in time
constant of Cai
2? transient
decay. Solid line is the linear
best ﬁt to the data (r
2 = 0.98). d
Correlation between fold
change in IBI and fold change in
the slow diastolic Cai
2? rise.
Solid line is the linear best ﬁt to
the data (r
2 = 0.73)
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123currents. These data suggest that the negative chronotropic
effect of muscarinic agonists is in part obtained via Cai
2?
transient inhibition and the subsequent reduction in cAMP.
Classical pathways in muscarinic agonist-induced
pacemaker slowing
In our rabbit single SAN cell preparation, we demonstrate
that muscarinic agonists inhibit pacemaker frequency
(Figs. 1, 2, 3, 4, 7) and cAMP production (Figs. 2d, 8)i na
concentration-dependent manner. Our data thus support the
classical view that cAMP is an important determinant of
pacemaker frequency. The classical view that activation of
IK,ACh is a cAMP-independent pathway by which musca-
rinic agonists exert their negative chronotropic effect [4]
(cf. Fig. 2a) is also supported by our data (Figs. 2e, f, 3).
Moreover, we demonstrated that NA stimulation, which is
known to increase cAMP production, reduced the contri-
bution of the cAMP-independent pathway IK,ACh to ACh-
mediated pacemaker slowing. This explains the limited
effect of ACh on the maximum diastolic potential seen in
Fig. 1a. In contrast, NA stimulation increased the contri-
bution of the cAMP-dependent pathway If to ACh-mediated
pacemaker slowing. This can be explained by the NA-
mediated increase in cAMP production.
Muscarinic agonists slow pacemaker rate by inhibition
of Cai
2? transients
The importance of Cai
2? in pacemaking has been demon-
strated in non-stimulated and NA-stimulated conditions. It
has been shown that blunting Cai
2? transients (by ryano-
dine) or chelating Cai
2? (by BAPTA) slowed or arrested
pacemaking and prevented NA-induced pacemaker acce-
leration [25]. Although ryanodine and BAPTA both inhibit
Cai
2? transients, it should be kept in mind that there are
several differences in actions between ryanodine and
BAPTA. For instance, BAPTA increases the intracellular
Ca
2? buffering power. Consequently, the free Cai
2? con-
centration will fall and any increase in [Ca
2?]i through
Ca
2? release (from the SR) or Ca
2? inﬂux (through ICa,L)i s
blunted and slowed. This will affect the LCRs, Cai
2?
transients and all Cai
2?-dependent currents including ICa,L.
Ryanodine, on the other hand, reduces the open probability
of the RyR channels. Consequently, less ryanodine chan-
nels are available for SR Ca
2? release. This will reduce
Fig. 8 Intracellular cAMP
production depends on Cai
2?
transients. cAMP was measured
in non-stimulated (a and c) and
NA-stimulated (b and d) SAN
cell samples, either pre-treated
with vehicle (open symbols)o r
Cai
2? transient inhibiting drugs
(ﬁlled symbols). a, b cAMP–
MCh relationship in the absence
(vehicle) and presence of 3 lM
ryanodine in non-stimulated (a)
and NA-stimulated (b) cells. c,
d cAmp–MCh relationship in
the absence (vehicle) and
presence of 25 lM BAPTA-AM
in non-stimulated (c) and NA-
stimulated (d) cells. All cAMP
values were normalized to the
control cAMP levels of non-
stimulated SAN cells in the
absence of ACh. Asterisks
indicate signiﬁcant difference
between vehicle and Cai
2?
transient inhibiting drug at the
associated MCh concentration
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123fractional SR Ca
2? release and the amplitude of LCRs and
Cai
2? transients. However, ryanodine will not blunt any
Ca
2? inﬂux and will affect Cai
2?-dependent modulation of
ICa,L to a lesser extent. These differences in actions
between ryanodine and BAPTA may explain their quanti-
tatively different effects on pacemaker frequency.
In the present study, we conﬁrm that Cai
2? transients
contribute to the intrinsic pacemaker activity of non-stimu-
lated SAN cells (Fig. 4b) and to pacemaker acceleration of
NA-stimulated cells (Fig. 4c). In addition, we provide
evidence for the involvement of Cai
2? transients in mus-
carinic agonist-induced pacemaker slowing.
First, both ryanodine and BAPTA-AM facilitated
pacemaker slowing at all ACh concentrations in NA-
stimulated SAN cells. In non-stimulated SAN cells, the
effects of ryanodine and BAPTA on ACh-mediated pace-
maker slowing were less abundant and restricted to low
ACh concentrations. The latter is likely explained by the
concomitant increase in minimum diastolic Cai
2? concen-
tration (Fig. 4a) and the subsequent activation of INCX.A
ryanodine-induced increase in diastolic [Ca
2?]i has been
previously reported in rabbit SAN cells [38]. The diastolic
Cai
2? increase was larger in the presence of ryanodine than
in the presence of BAPTA-AM. This could underlie the
quantitative differences between the effects of both agents
on ACh-mediated pacemaker slowing. Moreover, Bucchi
et al. [6] recently reported that ryanodine (3 lM) depo-
larizes the take-off potential of the AP, which by itself
slows pacemaker frequency.
Second, we show that ACh depresses all ﬁve (I–V) dis-
tinct phases of the Cai
2? transients (Fig. 5b, c, d, e, f) and
lowers the SR Ca
2? content (Fig. 6b) of rabbit SAN cells in
a concentration-dependent manner, all of which is com-
patible with reduced cAMP–PKA-dependent phosphoryla-
tion of the Cai
2? handling proteins. In accordance, in
NA-stimulated cells, where cAMP–PKA signaling is stim-
ulated, higher ACh concentrations were required to obtain a
similar level of the maximum systolic [Ca
2?]i (Fig. 5c),
slow diastolic [Ca
2?]i rise (Fig. 5f) and SR Ca
2? content
(Fig. 6b) as compared to non-stimulated SAN cells. More-
over, higher ACh concentrations were required to increase
the time constant of Cai
2? transient decay in NA-stimulated
cells (Fig. 5d). Of interest, the slow diastolic [Ca
2?]i rise
that probably reﬂects the LCRs proved the Cai
2? transient
parameter with the highest ACh-sensitivity (Fig. 5f).
Third, ACh was still able to slow pacemaker frequency
of non-stimulated SAN cells in a concentration-dependent
manner when the important contributors to ACh-mediated
pacemaker slowing, If and IK,ACh, were both inhibited
(Fig. 7b). Thus, other mechanisms, such as Cai
2? releases
[19], ICa,L [34, 43] and Ist [10], involved in ACh-mediated
pacemaker slowing must be active. Both the Cai
2? transient
decay and the slow diastolic Cai
2? rise of SAN cells with
inhibited If and IK,ACh showed close correlations with the
ACh-induced changes in interbeat interval (Fig. 7c, d),
suggesting that the ACh-mediated modulation of SERCA
activity and of LCRs, and thus the rate of SR Ca
2? reﬁlling
and release, are important determinants of ACh-mediated
pacemaker slowing. This is in accordance with previous
publications by Lakatta and co-workers who found strong
correlations between beating frequency and phospholam-
ban phosphorylation status, and beating frequency and the
periodicity of LCRs in rabbit SAN cells [27, 47].
Fourth, Cai
2? transient inhibition by ryanodine and
BAPTA-AM facilitated MCh-mediated inhibition of
cAMP, an important second messenger that is positively
correlated with pacemaker frequency (Figs. 2, 8).
The effect of ACh on Cai
2? transients can be explained
by reduced cAMP–PKA-dependent phosphorylation of
ryanodine receptors and phospholamban. These phosphory-
lation changes lead to reduced open probability of the
ryanodine receptor and to slower SERCA-mediated Cai
2?
re-uptake into the SR, respectively. Moreover, in voltage
clamp experiments, ACh inhibits the ICa,L of rabbit SAN
cells [51], which may result in Cai
2? transient inhibition.
Further experiments are required to elucidate the exact role
of ICa,L in ACh-mediated pacemaker slowing.
Membrane clock and calcium clock
The main mechanism by which Cai
2? is thought to interact
with the ‘‘membrane clock’’ is through electrogenic Ca
2?
extrusion via the Na
?/Ca
2? exchanger [3]. For instance,
NA stimulates cAMP–PKA-dependent phosphorylation of
Cai
2? handling proteins, thereby increasing the amplitude
and frequency of the LCRs and subsequently the contri-
bution of INCX to diastolic depolarization [3, 45]. It should
be taken into account, however, that various ion currents
can also be modulated by Cai
2? (e.g., ICa,L [39], If [35], the
T-type calcium current (ICa,T)[ 18], chloride currents [1,
44] and the slow delayed rectiﬁer current (IKs)[ 41]) and by
calmodulin or Ca
2?/calmodulin-dependent protein kinase
II (CaMKII) (e.g., ICa,L [9], ICa,T [21] and IKs [33]). In the
present study, we did not assess each of the ionic currents
that are affected by the muscarinic agonist-induced Cai
2?
transient changes, nor did we study the effect of muscarinic
agonists on LCRs as part of the ‘‘calcium clock’’. Never-
theless, our Cai
2? transient data are still relevant for
understanding the ‘‘calcium clock’’, since the Cai
2? tran-
sient and the ‘‘calcium clock’’ are interdependent [25].
LCRs ignite the AP by activating ICa,L, which resets the
‘‘calcium clock’’ and triggers a Cai
2? transient. Only after
the Cai
2? transient has sufﬁciently declined and enough
Ca
2? is restored in the SR, another LCR can occur.
Thus, muscarinic agonists slow SAN cell pacemaker
activity by inhibition of Cai
2? transients. However, the
84 Basic Res Cardiol (2010) 105:73–87
123relative contribution of Cai
2?-dependent mechanisms and
‘‘membrane clock’’ mechanisms, including inhibition of If
and activation of IK,ACh, to ACh-mediated pacemaker
slowing is difﬁcult to assess because they are so strongly
interdependent (see above). Only if we assume that ACh-
mediated pacemaker slowing is fully explained by the
action of ACh on If, IK,ACh and a Ca
2?-dependent mecha-
nism, we can estimate their relative contributions. Pace-
maker frequency of uninhibited SAN cells was slowed by
66, 79 and 100% when exposed to 50, 100 and 1,000 nM
ACh, respectively (Fig. 3b), whereas pacemaker frequency
of SAN cells with inhibited If and IK,ACh was slowed by 51,
58 and 72% when exposed to 50, 100 and 1,000 nM ACh,
respectively (Fig. 7b). Thus, one could say that at 50–
1,000 nM ACh, the Ca
2?-dependent mechanism is
responsible for &75% pacemaker slowing and the com-
bined inhibition of If and opening of IK,ACh for &25%
pacemaker slowing. Further experiments are required to
elucidate the ionic currents involved in the Ca
2?-dependent
mechanism of ACh-mediated pacemaker slowing.
Muscarinic agonists slow pacemaker rate by inhibition
of Cai
2?-stimulated cAMP production
It was recently demonstrated that basal cAMP levels are
almost tenfold higher in SAN cells as compared to atrial
and ventricular myocytes [46]. The presence of Ca
2?-
stimulated adenylyl cyclases in SAN cells may account for
the relatively high basal cAMP level [30] and PKA activity
[46]. The latter proved essential for the spontaneous
rhythmic LCRs and ‘‘calcium clock’’ in SAN cells. The
presence of these Ca
2?-stimulated adenylyl cyclases in
SAN cells [30] provides a potential indirect mechanism by
which Cai
2? inﬂuences cAMP-dependent ionic currents and
thus pacemaker frequency [5, 30].
Our data add functional evidence for the presence of a
Cai
2?-dependent cAMP production in rabbit SAN cells.
While the present paper was in preparation, Younes et al.
[49] published their work on Ca
2?-stimulated basal
adenylyl cyclase activity of rabbit SAN pacemaker cells.
In this study, they showed that rabbit SAN cells express
two Ca
2?-stimulated adenylyl cyclases (AC1 and AC8),
located in the lipid rafts, which are largely responsible
for the basal adenylyl cyclase activity and account for
&30% of the high basal cAMP levels in SAN cells. In
our non-stimulated SAN cells, Cai
2?-dependent cAMP
production contributes to 33% to the basal cAMP levels,
as demonstrated by the reduction in cAMP production on
inhibition by BAPTA (Fig. 8c). From our results and the
similar observations by Younes et al. [49], we conclude
that in rabbit SAN cells, Ca
2?-stimulated adenylyl cyc-
lases (AC1 and AC8) in part contribute to the basal
cAMP levels and that the Ca
2?–independent adenylyl
cyclases (AC5 and AC6) may provide the remaining
cAMP [48, 49].
In addition, from our data we conclude that the Cai
2?-
dependent cAMP production can provide the increase in
cAMP in NA-stimulated SAN cells. Thus, the NA-aug-
mented Cai
2? transients may have stimulated the extra
cAMP production required for pacemaker acceleration
(Figs. 2d, 8d). This ﬁnding contrasts with the observation
by Younes et al. [49] that BAPTA did not affect the cAMP
production in SAN cells stimulated with a b-adrenergic
agonist, but it is in line with the earlier report of Bucchi
et al. [5] who showed that a membrane-permeable cAMP
analog restored If modulation by b-adrenergic agonists in
ryanodine treated SAN cells.
Furthermore, we demonstrate that Cai
2? transient inhi-
bition facilitates the ACh-mediated inhibition of cAMP
production in non-stimulated SAN cells (Fig. 8a, c). Thus,
muscarinic agonist-mediated inhibition of the Cai
2? tran-
sient may in part underlie its inhibitory effect on cAMP
production and pacemaker slowing (Fig. 2c). The remain-
ing muscarinic agonist-induced cAMP reduction is likely
obtained via the classical Gi-mediated inhibition of aden-
ylyl cyclases [13].
Limitations
The present study has several limitations. First, it is difﬁ-
cult to draw ﬁrm conclusions with respect to the role of
Cai
2? transients in muscarinic agonist-induced pacemaker
slowing due to the interdependence of Cai
2? transients,
cAMP content and pacemaker frequency. Ideally, one
should vary one parameter while keeping other parameters
constant. Unfortunately, this is impossible in SAN cells,
even under AP clamp conditions, where pacemaker fre-
quency, but not ion ﬂow, is controlled. Nevertheless, our
observations that muscarinic agonists reduce pacemaker
frequency, Cai
2? transients and cAMP content dose
dependently, and that Cai
2? transient inhibition (by ryano-
dine or BAPTA) in turn facilitates muscarinic agonist-
mediated pacemaker slowing and cAMP inhibition
provides valuable insight into the processes underlying
pacemaker frequency modulation. Second, the exact spatial
and temporal relation between Cai
2? and cAMP may be
highly complex, since local concentration differences of
both exist within a cell [48]. Phosphodiesterases, which in
our cAMP assays were inhibited to allow cAMP accumu-
lation, underlie these spatial differences and have been
recently shown to be constitutively active in SAN cells
[47]. Nevertheless, also in PDE-inhibited SAN cells, MCh,
NA,ryanodineandBAPTAchangedcAMPlevels,indicating
that cAMP production was still subject to modulation.
Third, it should be noted that 2 mM cesium not only
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123largely inhibits If [15], but also slightly reduces outward
potassium current [50], which may have led to an under-
estimation of the contribution of If to pacemaker slowing in
our experiments. However, ‘‘more speciﬁc’’ If channel
blockers also affect other ion currents present in SAN cells
[2]. In addition, If channel blockers may also directly
inﬂuence Cai
2? transients, since the If channel has been
recently shown to be permeable to calcium ions [31]. A
further limitation is that IK,ACh may not have been com-
pletely blocked by 100 nM tertiapin, as suggested by the
experiments of Kitamura et al. [16], who found a &95%
block of IK,ACh by 100 nM tertiapin in rabbit atrial myo-
cytes. Therefore, the actual contribution of IK,ACh to
ACh-mediated pacemaker slowing may have been under-
estimated in the present study. Moreover, the potential
contribution of ICa,L to ACh-mediated pacemaker slowing
has not been investigated because of the lack of appropriate
pharmacological tools to assess the role of ICa,L without
stopping pacemaking or affecting the action potential
waveform. Finally, MCh is less potent compared to ACh in
stimulating muscarinic receptor type 2 [40]. Therefore, a
direct quantitative comparison between the cAMP–MCh
curves and the frequency–ACh response curves is not
allowed.
Conclusions
We provide evidence that muscarinic agonists not only
slow pacemaker activity by inhibition of cAMP-dependent
ionic currents and activation of IK,ACh, but also by inhibi-
tion of Cai
2? transients, which reduces cAMP content
through inhibition of Cai
2?-stimulated cAMP production.
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